000 01591cam a2200421 i 4500
005 20250920011741.0
008 170929s2017 enka bi 001 0 eng
020 _a9781782624592
_q(print)
_cRM959.08
020 _a1782624597
020 _z9781782629276 (PDF)
020 _z781782629696 (ePUB)
039 9 _a201710111000
_bfida
_y09-29-2017
_zruzini
040 _aNLM
_beng
_cNLM
_erda
_dBTCTA
_dBDX
_dCOD
_dOCLCF
_dYDXCP
_dOCLCO
_dDLC
_dUKM
_erda
090 _aQV745.A441 2017 9
090 _aQV745
_b.A441 2017 9
245 0 0 _aAllosterism in drug discovery /
_cedited by Dario Doller.
264 1 _aCambridge :
_bRoyal Society Of Chemistry,
_c[2017].
300 _axix, 437 pages :
_billustrations ;
_c24 cm.
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
490 1 _aRSC drug discovery series,
_x2041-3203 ;
_v56.
504 _aIncludes bibliographical references and index.
586 _aQueen's Awards for Enterprise: International Trade, 2013
650 2 _aDrug Discovery.
650 2 _aAllosteric regulation.
700 1 _aDoller, Dario,
_eeditor.
710 2 _aRoyal Society of Chemistry (Great Britain),
_eissuing body.
830 0 _aRSC drug discovery series ;
_v56.
_x2041-3203
907 _a.b16513289
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV745.A441 2017 9
914 _avtls003626142
990 _afn
991 _aFakulti Farmasi, KKL
998 _ad
_b2017-03-09
_cm
_da
_feng
_genk
_y0
_z.b16513289
999 _c692295
_d692295